Tech Company Financing Transactions

Alto Neuroscience Funding Round

Alto Neuroscience closed a $25 million Series B funding round on 1/30/2023. Backers included K2 HealthVentures.

Transaction Overview

Company Name
Announced On
1/30/2023
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series B
Investors

K2 HealthVentures (Lead Investor)

Proceeds Purpose
Funding to date will support Alto through a total of four Phase 2 readouts with four novel drug candidates across three indications, as well as the continued evolution of Alto's Precision Psychiatry Platform.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
369 South San Antonio Rd.
Los Altos, CA 94022
USA
Phone
Undisclosed
Email Address
Overview
Alto Neuroscience is a clinical-stage biopharmaceutical company that integrates the biology of the patient into drug development to improve the lives of people with mental health conditions.
Profile
Alto Neuroscience LinkedIn Company Profile
Social Media
Alto Neuroscience Company Twitter Account
Company News
Alto Neuroscience News
Facebook
Alto Neuroscience on Facebook
YouTube
Alto Neuroscience on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Amit Etkin
  Amit Etkin LinkedIn Profile  Amit Etkin Twitter Account  Amit Etkin News  Amit Etkin on Facebook
Chief Medical Officer
Adam Savitz
  Adam Savitz LinkedIn Profile  Adam Savitz Twitter Account  Adam Savitz News  Adam Savitz on Facebook
Chief Operating Officer
Daniel Segal
  Daniel Segal LinkedIn Profile  Daniel Segal Twitter Account  Daniel Segal News  Daniel Segal on Facebook
Co-Founder
Wei Wu
  Wei Wu LinkedIn Profile  Wei Wu Twitter Account  Wei Wu News  Wei Wu on Facebook
Vice President
Bruce Morimoto
  Bruce Morimoto LinkedIn Profile  Bruce Morimoto Twitter Account  Bruce Morimoto News  Bruce Morimoto on Facebook
VP - Bus. Development
Nick Smith
  Nick Smith LinkedIn Profile  Nick Smith Twitter Account  Nick Smith News  Nick Smith on Facebook
VP - Operations
Lesley Parker
  Lesley Parker LinkedIn Profile  Lesley Parker Twitter Account  Lesley Parker News  Lesley Parker on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/30/2023: Sovereign Labs venture capital transaction
Next: 1/30/2023: Caura venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary